Vision and Mission

microDAO envisions a world where the spread of AMR is reduced and no longer threatens global health security. Our mission is to accelerate the development and ensure equitable access to new AMR solutions by:

1. Funding evidence gathering and data collection to identify the most pressing needs and promising approaches

2. Supporting the development of novel antimicrobials, vaccines, and diagnostic methods based on collected evidence, with a strategic focus on:

   1. Antimicrobials and vaccines: Early-stage projects (hit-to-lead or earlier) targeting pathogens with limited pipeline candidates

   2. Diagnostics: Early-stage development of point-of-care tools

3. Ensuring developed solutions reach those who need them most through equitable access programs

By concentrating on evidence-based funding of early-stage research, microDAO aims to:

• Reduce uncertainty in the drug discovery process through better data

• Revitalise the antimicrobial development ecosystem with sustainable funding

• Enable solutions that respond to documented local and global needs

• Increase the impact of existing AMR initiatives through improved coordination

• Create clear paths to market for promising innovations

This strategy will help ensure a steady flow of evidence-based, needs-driven solutions entering the development pipeline, while our community tools provide both the insights to guide investment and the capabilities to accelerate development.